For three weeks, beginning May 4 and ending May 24, the Department of Health and Human Services said it delivered to states, territories and government agencies more than 12,000 cases of 40 vials each of remdesivir to help treat COVID-19 infections.

Every state and territory has received at least one shipment, and hospitals are asked to continue inputting data for future allocations. The administration said 80% of the allocated drugs was based on the number of confirmed or suspected COVID-19 cases reported in the TeleTracking platform. Less than 10% of Gilead Sciences Inc.’s original 600,000 vial donation is being held for emerging hotspots, and Gilead said it plans to donate an additional 330,000 vials by the end of June.

Related News Articles

Headline
The Department of Health and Human Services Dec. 10 amended the Public Readiness and Emergency Preparedness Act declaration for COVID-19, extending liability…
Headline
AHA's latest social media toolkit for encouraging vaccination against the flu and COVID-19 provides fall-themed social media posts and graphics. Download the…
Headline
The Centers for Disease Control and Prevention last week endorsed a recommendation for people aged 65 and older and for immunocompromised individuals to…
Headline
The Centers for Medicare & Medicaid Services Oct. 22 released final guidance detailing reporting requirements for the hospital respiratory data condition…
Headline
The Centers for Disease Control and Prevention is reminding clinicians and other health care workers to take necessary steps to keep themselves and their…
Headline
The National Institutes of Health Oct. 10 released results of a study that found that infection from COVID-19 in the first wave of the pandemic appeared to…